Keytruda Immune Response Clinical Trials Checkpoint Inhibitors Vaccines Immune Checkpoints T-cell Therapy Treatment Methods Treatment Outcomes Resistance Mechanisms CAR-T Cell Therapy Tumor Immune Microenvironment Emotional Impact MDNA11 Dendritic Cells Patient Outcomes Treatment Options mRNA Technology Regulatory T Cells Cytokine Signaling Drug Development Tim Keller Natural Killer Cells Melanoma mRNA Vaccine Chemotherapy Vaccine Development Innovative Strategies Targeted Therapy mRNA Therapies Eosinophils Mitochondrial DNA Histotripsy Cellular Immunotherapy Research Research Studies Peptide Identification Chimeric Antigen Receptor Therapy Radiotherapy CAR T Therapy Mental Health T Cells Fundraising Events CAR T Cell Therapy
The decision signals the agency’s demand for stronger, more consistent evidence than Replimune’s single‑arm data.
